Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SAT1 | P21673 | 2/20 | 0.35 |
| ▸ | MME | P08473 | 1/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
| ▸ | CPA1 | P15085 | 1/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | KDM1A | O60341 | 2/20 | 0.34 |
| ▸ | CTH | P32929 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30597856 | 1.00 | CYP2C19 (0.43) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL8665227 | 0.97 | FFAR3 (0.39) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL30891500 | 0.91 | CYP2C19 (0.52) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL17364022 | 0.89 | CYP2C19 (0.39) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL18160753 | 0.87 | LMNA (0.41) | TSHRCA1CA2CTHEGLN1 | |
| SCHEMBL1134677 | 0.87 | LMNA (0.41) | TSHRCA1CA2CTHEGLN1 | |
| SCHEMBL8353274 | 0.85 | CYP2C19 (0.43) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL25121441 | 0.85 | PAOX (0.45) | MEN1KMT2AFFAR3HDAC3HDAC1 | |
| SCHEMBL4969545 | 0.85 | PAOX (0.45) | MEN1KMT2AFFAR3HDAC3HDAC1 | |
| SCHEMBL41068 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024107762-A2 | DECREASED RETENTION OF MINIPROTEINS IN KIDNEY | AKTIS ONCOLOGY, INC. (US) | 2024-05-23 | — | — | WO | disclosed |
| CN-117917989-A | Use of a reversible metal electrodeposited electrolyte with pH-adjustable, dynamic glass element with high opacity and excellent rest stability, and electrolyte useful therefor | 代表内华达大学雷诺分校的内华达高等教育系统董事会 | 2024-04-23 | — | — | CN | disclosed |
| EP-1381392-A4 | SYNTHETIC CATALYST FOR SELECTIVE CLEAVAGE OF PROTEIN AND METHOD FOR SELECTIVE CLEAVAGE OF PROTEIN USING THE SAME | TS CORP (KR) | 2005-03-23 | — | — | EP | disclosed |
| EP-1381392-A1 | SYNTHETIC CATALYST FOR SELECTIVE CLEAVAGE OF PROTEIN AND METHOD FOR SELECTIVE CLEAVAGE OF PROTEIN USING THE SAME | TS Corporation (KR) | 2004-01-21 | — | — | EP | disclosed |
| US-20020165365-A1 | Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same | ARTZYME BIOTECH CORPORATION (KR) | 2002-11-07 | — | — | US | disclosed |
| WO-2002085413-A1 | SYNTHETIC CATALYST FOR SELECTIVE CLEAVAGE OF PROTEIN AND METHOD FOR SELECTIVE CLEAVAGE OF PROTEIN USING THE SAME | TS CORPORATION (KR) | 2002-10-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020165365-A1 | Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same | CPN1, RNPEP, ANPEP | CYP2C19 4411/4885MEN1 1581/4885GLA 671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.